
The evidence for several sites of activity within the dynorphin sequence is reviewed. A number of endocrine and CNS peptides are believed to contain several sites of biological activity. Data from a number of laboratories is consistent with such a mechanism for the opioid peptide dynorphin. These findings stem from structure-activity studies in which nonopiate fragments of dynorphin sometimes show biological activity and from the failure of naloxone to reverse some effects of dynorphin. These results are discussed in terms of the possible physiological relevance of such nonopiate actions.
Structure-Activity Relationship, Naloxone, beta-Endorphin, Animals, Humans, Endorphins, Dynorphins, Hippocampus, Rats
Structure-Activity Relationship, Naloxone, beta-Endorphin, Animals, Humans, Endorphins, Dynorphins, Hippocampus, Rats
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
